Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer

British Journal of Cancer

Volumn 80, Issue 3-4, 1999, Pages 495-503

  Holten Andersen, M N ^a   Murphy, G ^b   Nelsen, H J ^d   Pedersen, A N ^a,c   Christensen, I J ^a   Hoyer Hansen G ^a   Brunner N ^a   Stephens, R W ^a  

^a FINSEN LABORATORY   (Denmark)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Blood donors; Cancer; ELISA; Plasma; TIMP 1

Indexed keywords

CITRIC ACID; EDETIC ACID; HEPARIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD DONOR; BLOOD LEVEL; BREAST CANCER; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD DONORS; BREAST NEOPLASMS; CITRATES; COLORECTAL NEOPLASMS; EDETIC ACID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOBLOTTING; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEX FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0032949022     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690384     Document Type: Article

References (39)

1. Baker T, Tickle S, Wasan H, Docherty A, Isenberg D and Waxman J (1994) Serum metalloproteinases and their inhibitors: markers for malignant potential. Br J Cancer 70: 506-512
2. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A and Engler JA (1993) Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4: 197-250
3. Clark IM, Powell LK, Wright JK and Cawston the (1991) Polyclonal and monoclonal antibodies against human tissue inhibitor of metalloproteinases (TIMP) and the design of an enzyme-linked immunosorbent assay to measure TIMP. Matrix 11: 76-85
4. Cooksley S, Hipkiss JB, Tickle SP, Holmes IE, Docherty AJ, Murphy G and Lawson AD (1990) Immunoassays for the detection of human collagenase, stromelysin, tissue inhibitor of metalloproteinases (TIMP) and enzyme-inhibitor complexes. Matrix 10: 285-291
5. Cooper TW, Eisen AZ, Stricklin GP and Welgus HG (1985) Platelet-derived collagenase inhibitor: characterization and subcellular localization. Proc Natl Acad Sci USA 82: 2779-2783
6. De Nictolis M, Garbisa S, Lucarini G, Goteri G, Masiero L, Ciavattini A, Garzetti GG, Stetler-Stevenson WG, Fabris G, Biagini G and Prat J (1996) 72-kilodalton type IV collagenase, type IV collagen, and Ki 67 antigen in serous tumors or the ovary: a clinicopathologic, immunohistochemical, and serological study. Int J Gynecol Pathol 15: 102-109
7. DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE and Taylor SM (1992) Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52: 701-708
8. Deng G, Curriden SA, Wang S, Rosenberg S and Loskutoff DJ (1996) Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J Cell Biol 134: 1563-1571
9. Fong KM (1996) TIMP1 and adverse prognosis in non-small cell lung cancer. Clin Cancer Res 2: 1369-1372
10. Frandsen TL, Stephens RW, Pedersen AN, Engelholm LH, Holst-Hansen C and Brünner N (1998) Plasminogen activator inhibitor type I (PAI-1) in cancer: a potential new target for antiinvasive and antimetastatic therapy. Drugs of the Future 23: 873-883
11. Fujimoto N, Zhang J, Iwata K, Shinya T, Okada Y and Hayakawa T (1993) A one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases-2 using monoclonal antibodies. Clin Chim Acta 220: 31-45
12. Fung K, Nowak L, Lein M, Henke W, Schnorr D and Loening SA (1996) Role of specimen collection in preanalytical variation of metalloproteinases and their inhibitors in blood. Clin Chem 42: 2043-2045
13. Gohji K, Fujimoto N, Fujii A, Komìyama T, Okawa J and Nakajima M (1996) Prognostic significance of circulating matrix metalloproteínase-2 to tissue inhibitor of metalloproteinases-2 ratio in recurrence of urothelial cancer after complete resection. Cancer Res 56: 3196-3198
14. Goldberg GI, Strongin A, Collier IE, Genrich LT and Marmer BL (1992) Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 267: 4583-4591
15. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E and Iwata K (1992) Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 298: 29-32
16. Hembry RM, Murphy G and Reynolds JJ (1985) Immunolocalization of tissue inhibitor of metalloproteinases (TIMP) in human cells. Characterization and use of a specific antiserum. J Cell Sci 73: 105-119
17. Jung K, Nowak L, Lein M, Henke W, Schnorr D and Loening SA (1996) What kind of specimen should be selected for determining tissue inhibitor of metalloproteinase-1 (TIMP-1) in blood? Clin Chim Acta 254: 97-100
18. Kawano N, Osawa H, Ito T, Nagashima Y, Hirahara F, Inayama Y, Nakatani Y, Kimura S, Kitajima H, Koshikawa N, Miyazaki K and Kitamura H (1997) Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study. Hum Pathol 28: 613-622
19. Khokha R and Waterhouse P (1993) The role of tissue inhibitor of metalloproteinase-1 in specific aspects of cancer progression and reproduction. J Neurooncol 18: 123-127
20. Khokha R, Zimmer MJ, Graham CH, Lala PK and Waterhouse P (1992a) Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J Natl Cancer Inst 84: 1017-1022
21. Khokha R, Zimmer MJ, Wilson SM and Chambers AF (1992b) Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo. Clin Exp Metastasis 10: 365-370
22. Kleiner Jr DE, Tuuttila A, Tryggvason K and Stetler-Stevenson WG (1993) Stability analysis of latent and active 72-kDa type IV collagenase: the role of tissue inhibitor of metalloproteinases-2 (TIMP-2). Biochemistry 32: 1583-1592
23. Kodama S, Yamashita K, Kishi J, Iwata K and Hayakawa T (1989) A sandwich enzyme immunoassay for collagenase inhibitor using monoclonal antibodies. Matrix 9: 1-6
24. Liotla LA, Steeg PS and Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336
25. MacDougall JR and Matrisian LM (1995) Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 14: 351-362
26. Matrisian LM (1992) The matrix-degrading metalloproteinases. Bioessays 14: 455-463
27. Mimori K, Mori M, Shiraishi T, Fujie T, Baba K, Haraguchi M, Abe R, Ueo H and Akiyoshi T (1997) Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma. Br J Cancer 76: 531-536
28. r 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT 1080 tumor cells. Cancer Res 50: 6162-6170
29. Moutsiakis D, Mancuso P, Krutzsch H, Stetler-Stevenson WG and Zucker S (1992) Characterization of metalloproteinases and tissue inhibitors of metalloproteinases in human plasma. Connect Tissue Res 28: 213-230
30. Murphy G, Houbrechts A, Cockett MI, Williamson RA, O'Shea M and Docherty AJ (1991) The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. Biochemistry 30: 8097-8102
31. Nuovo GJ, MacConnell PB, Simsir A, Valea F and French DL (1995) Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res 55: 267-275
32. Stetler-Stevenson WG, Krutzsch HC and Liotta LA (1989) Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 264: 17374-17378.
33. Stetler-Stevenson WG, Liotta LA and Kleiner Jr DE (1993) Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 7: 1434-1441
34. Stetler-Stevenson WG, Hewitt R and Corcoran M (1996) Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin Cancer Biol 7: 147-154
35. Thorgeirsson UP, Lindsay CK, Cottam DW and Gomez DE (1993) Tumor invasion, proteolysis, and angiogenesis. J Neurooncol 18: 89-103.
36. Welgus HG, Jeffrey JJ, Eisen AZ, Roswit WT and Stricklin GP (1985) Human skin fibroblast collagenase: interaction with substrate and inhibitor. Coll Relat Res 5: 167-179
37. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA and Goldberg GI (1989) SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages J Biol Chem 264: 17213-17221
38. Yoshiji H, Gomez DE and Thorgeirsson UP (1996) Enhanced RNA expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in human breast cancer. Int J Cancer 69: 131-134
39. Zucker S, Lysik RM, DiMassimo BI, Zarrabi HM, Moll UM, Grimson R, Tickle SP and Docherty AJ (1995) Plasma assay of gelatinase B: tissue inhibitor of metalloproteinase complexes in cancer. Cancer 76: 700-708